Late Donor-Specific Antibody (Especially Class II) Development is Associated with an Increased Risk for Cardiac Allograft Vasculopathy.

被引：0
|
作者：
Kransdorf, E. [1 ]
Patel, J. [1 ]
Kittleson, M. [1 ]
Levine, R. [1 ]
Dimbil, S. [1 ]
Geft, D. [1 ]
Chang, D. [1 ]
Czer, L. [1 ]
Kobashigawa, J. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B73
引用
收藏
页码：653 / 653
页数：1
相关论文
共 50 条
  • [1] The effects of donor-specific antibody characteristics on cardiac allograft vasculopathy
    Wang, Maggie
    Patel, Nikhil J.
    Zhang, Xiaohai
    Kransdorf, Evan P.
    Azarbal, Babak
    Kittleson, Michelle M.
    Czer, Lawrence S. C.
    Kobashigawa, Jon A.
    Patel, Jignesh K.
    CLINICAL TRANSPLANTATION, 2021, 35 (12)
  • [2] The Effects of Donor-Specific Antibody Characteristics on Cardiac Allograft Vasculopathy
    Wang, M.
    Patel, N.
    Kransdorf, E.
    Azarbal, B.
    Zhang, X.
    Kobashigawa, J. A.
    Patel, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S41 - S41
  • [3] Cardiac allograft vasculopathy - IgM antibody responses to donor-specific vascular endothelium
    Hosenpud, JD
    Mauck, KA
    Hogan, KB
    TRANSPLANTATION, 1997, 63 (11) : 1602 - 1606
  • [4] DETERMINANTS AND OUTCOMES OF CARDIAC ALLOGRAFT VASCULOPATHY: MAJOR ROLE OF DONOR-SPECIFIC ANTIBODY
    Racape, Maud
    Bories, Marie-Cecile
    Varnous, Shaida
    Rouvier, Philippe
    Guillemain, Romain
    Bruneval, Patrick
    Taupin, Jean-Luc
    Lefaucheur, Carmen
    Loupy, Alexandre
    TRANSPLANT INTERNATIONAL, 2017, 30 : 144 - 144
  • [5] Donor-Specific Antibodies to Class II Antigens Are Associated With Accelerated Cardiac Allograft Vasculopathy: A Three-Dimensional Volumetric Intravascular Ultrasound Study
    Topilsky, Yan
    Gandhi, Manish J.
    Hasin, Tal
    Voit, Laurie L.
    Raichlin, Eugenia
    Boilson, Barry A.
    Schirger, John A.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Rodeheffer, Richard J.
    Frantz, Robert P.
    Kushwaha, Sudhir S.
    Lerman, Amir
    Pereira, Naveen L.
    TRANSPLANTATION, 2013, 95 (02) : 389 - 396
  • [6] Donor-Specific Antibody Is a Major Independent Predictor of Accelerated Heart Allograft Vasculopathy (CAV).
    Bories, M.
    Varnous, S.
    Lefaucheur, C.
    Rouvier, P.
    Guillemain, R.
    Bruneval, P.
    Van Huyen, J. Duong
    Loupy, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 290 - 290
  • [7] Production of donor specific HLA class II antibodies is associated with cardiac graft vasculopathy
    不详
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2005, 32 (04) : 261 - 261
  • [8] Pathology Antibody-Mediated Rejection Plus Circulating Donor-Specific Antibodies Increase Development of Cardiac Allograft Vasculopathy After Heart Transplantation
    Kittleson, M.
    Patel, J.
    Czer, L.
    Chang, D.
    Dimbil, S.
    Levine, R.
    Lam, N.
    Bleiker, R.
    Geft, D.
    Ramzy, D.
    Zhang, X.
    Luthringer, D.
    Kobashigawa, J. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S437 - S438
  • [9] PATHOLOGY ANTIBODY-MEDIATED REJECTION PLUS CIRCULATING DONOR-SPECIFIC ANTIBODIES INCREASE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Lam, N.
    Dimbil, S.
    Levine, R.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 98 - 99
  • [10] Determinants and outcomes of cardiac allograft vasculopathy: major role of donor specific antibody
    Bonnet, G.
    Racape, M.
    Bories, M. C.
    Varnous, S.
    Rouvier, P.
    Guillemain, R.
    Bruneval, P.
    Taupin, J. L.
    Lefaucheur, C.
    Loupy, A.
    Jouven, X.
    EUROPEAN HEART JOURNAL, 2018, 39 : 681 - 681
12345